Medicinal Chemistry News and Research

RSS
MD Anderson and Yingli Pharma announce strategic alliance to advance many oncology programs

MD Anderson and Yingli Pharma announce strategic alliance to advance many oncology programs

Evaporators assist academic drug discovery

Evaporators assist academic drug discovery

Study shows that key parts of human immunity are shared in bacteria

Study shows that key parts of human immunity are shared in bacteria

Neurologist receives ERC grant to study novel light-activated drugs with antiepileptic effects

Neurologist receives ERC grant to study novel light-activated drugs with antiepileptic effects

Metrion Biosciences expands ion channel drug discovery service capabilities and in-house expertise

Metrion Biosciences expands ion channel drug discovery service capabilities and in-house expertise

Clinical drug research for the treatment of CNS and neurological disorders

Clinical drug research for the treatment of CNS and neurological disorders

Experimental compound reduces diabetic complications in mice

Experimental compound reduces diabetic complications in mice

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

Oral PCSK9-inhibitor highly effective at reducing high levels of LDL cholesterol, studies show

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Discovery of carbon-carbon bond-forming reaction opens the door to more stable drugs

Discovery of carbon-carbon bond-forming reaction opens the door to more stable drugs

TTUHSC investigator evaluates the potential of neurolysin as a therapeutic target for stroke

TTUHSC investigator evaluates the potential of neurolysin as a therapeutic target for stroke

COVID Moonshot receives key funding to accelerate drug discovery efforts

COVID Moonshot receives key funding to accelerate drug discovery efforts

Study pinpoints a potential pathway for treating epileptic seizures in patients with autism

Study pinpoints a potential pathway for treating epileptic seizures in patients with autism

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

Heidelberg researchers focus on developing drugs against flavi- and coronaviruses

Heidelberg researchers focus on developing drugs against flavi- and coronaviruses

Designing antimalarials with multiple targeting mechanisms of action

Designing antimalarials with multiple targeting mechanisms of action

Could a plant metabolite in liverworts be a potent antiviral against SARS-CoV-2 and other RNA viruses?

Could a plant metabolite in liverworts be a potent antiviral against SARS-CoV-2 and other RNA viruses?

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies